Bristol Myers Squibb reported $27.11B in Current Assets for its first fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
ALKERMES ALKS:US 1.01B 104.96M
Amgen AMGN:US $ 21299M 155M
AstraZeneca AZN:LN 18.74B 809M
Astrazeneca AZN:US 18.74B 809M
Biogen BIIB:US $ 6719.5M 167.6M
Bristol Myers Squibb BMY:US $ 27111M 3081M
Catalent CTLT:US $ 2774.5M 255.6M
Coherus Biosciences CHRS:US $ 617.26M 150.22M
Eli Lilly And LLY:US $ 16604.5M 857.6M
Endo International Ordinary Shares ENDP:US $ 2495.23M 81.97M
Gilead Sciences GILD:US $ 13166M 2830M
GlaxoSmithKline GSK:LN 18.52B 1.72B
Gw Pharmaceuticals GWPH:US $ 718.73M 10.8M
Horizon Pharma HZNP:US $ 1831.37M 1239.04M
Intercept Pharmaceuticals ICPT:US $ 487.56M 58.18M
JAZZ PHA JAZZ:US $ 3166.9M 327.33M
Johnson & Johnson JNJ:US $ 52533M 1296M
Lannett LCI:US $ 369.91M 37.89M
Medtronic MDT:US $ 26347M 311M
Novartis NOVN:VX 22.2B 7.48B
Phibro Animal Health PAHC:US $ 471.72M 5.45M
Prestige Brands PBH:US $ 269.83M 31.38M
Regeneron Pharmaceuticals REGN:US $ 10055.1M 276M
Teva Pharmaceutical Industries TEVA:US $ 12401M 604M
United Therapeutics UTHR:US $ 2014.3M 152.9M
Zoetis ZTS:US $ 6794M 183M